Foundayo targets the exact same GLP-1 receptor as injectable medications like semaglutide
In many other countries, these peptides are strictly regulated prescription medicines
This receptor distribution suggests that semaglutide may exert both direct and indirect effects on cardiovascular function beyond glucose control
Whilst GLP-1 receptor agonists are not licensed for treating inflammatory diseases, emerging clinical evidence suggests potential benefits in several conditions characterised by chronic inflammation
Dreishpoon MB, Bick NR, Petrova B, Warui DM, Cameron A, Booker SJ, et al
Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: a randomized controlled trial